Review
doi: 10.1016/j.drudis.2013.08.021.
Epub 2013 Aug 31.
Thymoquinone: fifty years of success in the battle against cancer models
Affiliations
- PMID: 24001594
- DOI: 10.1016/j.drudis.2013.08.021
Item in Clipboard
Review
Thymoquinone: fifty years of success in the battle against cancer models
Drug Discov Today.
2014 Jan.
Abstract
Thymoquinone (TQ), the main active constituent of black seed essential oil, exhibits promising effects against inflammatory diseases and cancer. TQ, modulates signaling pathways that are key to cancer progression, and enhances the anticancer potential of clinical drugs while reducing their toxic side effects. Considering that TQ was isolated 50 years ago, this review focuses on TQ's chemical and pharmacological properties and the latest advances in TQ analog design and nanoformulation. We discuss our current state of knowledge of TQ's adjuvant potential and in vivo antitumor activity and highlight its ability to modulate the hallmarks of cancer.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy.Biomed Pharmacother. 2019 Jul;115:108783. doi: 10.1016/j.biopha.2019.108783. Epub 2019 May 3. Biomed Pharmacother. 2019. PMID: 31060003 Review.
-
Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn.Pharmacol Res. 2018 Mar;129:357-364. doi: 10.1016/j.phrs.2017.11.023. Epub 2017 Nov 21. Pharmacol Res. 2018. PMID: 29162539 Review.
-
Mechanistic perspectives on cancer chemoprevention/chemotherapeutic effects of thymoquinone.Mutat Res. 2014 Oct;768:22-34. doi: 10.1016/j.mrfmmm.2014.05.003. Epub 2014 May 27. Mutat Res. 2014. PMID: 25847385 Review.
-
Terpene conjugates of the Nigella sativa seed-oil constituent thymoquinone with enhanced efficacy in cancer cells.Chem Biodivers. 2010 Jan;7(1):129-39. doi: 10.1002/cbdv.200900328. Chem Biodivers. 2010. PMID: 20087986
-
Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer.Curr Drug Targets. 2018;19(1):70-80. doi: 10.2174/1389450118666170612095959. Curr Drug Targets. 2018. PMID: 28606050 Review.
Cited by
-
Thymoquinone suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation, migration and neointimal formation.J Cell Mol Med. 2019 Dec;23(12):8482-8492. doi: 10.1111/jcmm.14738. Epub 2019 Oct 22. J Cell Mol Med. 2019. PMID: 31638340 Free PMC article.
-
Anticancer and Anti-Metastatic Role of Thymoquinone: Regulation of Oncogenic Signaling Cascades by Thymoquinone.Int J Mol Sci. 2022 Jun 5;23(11):6311. doi: 10.3390/ijms23116311. Int J Mol Sci. 2022. PMID: 35682990 Free PMC article. Review.
-
Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway.J Biosci. 2017 Dec;42(4):547-554. doi: 10.1007/s12038-017-9708-3. J Biosci. 2017. PMID: 29229873
-
Development of a Thymoquinone Polymeric Anticancer Nanomedicine through Optimization of Polymer Molecular Weight and Nanoparticle Architecture.Pharmaceutics. 2020 Aug 27;12(9):811. doi: 10.3390/pharmaceutics12090811. Pharmaceutics. 2020. PMID: 32867015 Free PMC article.
-
Thymoquinone Increases the Sensitivity of SW-480 Colon Cancer Cells to 5-Fluorouracil.Biomed Res Int. 2024 Jul 9;2024:6231095. doi: 10.1155/2024/6231095. eCollection 2024. Biomed Res Int. 2024. PMID: 39015603 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
